Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Hepatol. Nov 27, 2020; 12(11): 1004-1019
Published online Nov 27, 2020. doi: 10.4254/wjh.v12.i11.1004
Table 2 Sample characteristics for liver disease, n = 379
Variables
n (%)
NAFLD
Yes379 (100.0)
No0 (0.0)
Hepatic steatosis
Absent0 (0.0)
Discreet159 (42.0)
Moderate104 (27.4)
Accented84 (22.2)
Massive32 (8.4)
Ballooning
Absent91 (24.0)
Discreet221 (58.3)
Moderate18 (4.7)
Accented49 12.9)
Massive0 (0.0)
Lobular inflammation
Absent243 (64.1)
Discreet100 (26.4)
Moderate28 (7.4)
Accented8 (2.1)
Massive0 (0.0)
NASH
Absent83 (21.9)
Grade 1201 (53.0)
Grade 267 (17.7)
Grade 328 (7.4)
Grade 40 (0.0)
Absent216 (57.0)
Grade 186 (22.7)
Grade 244 (11.6)
Grade 333 (8.7)
Grade 40 (0.0)
Cirrhosis
Yes0 (0.0)
No379 (100.0)